Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Trial ID or NCT#

NCT01099267

Status

not recruiting iconNOT RECRUITING

Purpose

Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).

Official Title

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Must have been enrolled in the Celgene protocol CC-5013-MDS-003 study.2. Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (i.e. next of kin, legal representative) will be obtained prior to collection of data).
Exclusion Criteria:
  1. 1\. Consent refused for any reason at current or long-term follow up completed in 2007 (long-term follow up: survival data collection completed to obtain further safety information on CC-5013-MDS-003 discontinued subjects from May - October 2007).

Investigator(s)

Peter L Greenberg
Peter L Greenberg
Hematologist-Oncologist
Professor of Medicine (Hematology), Emeritus

Contact us to find out if this trial is right for you.

Contact

Cancer Clinical Trials Office
650-498-7061